Cathie Wood Is Buying Teladoc. Should You?
Investors like to keep a close eye on the activity of fund managers and billionaires, looking for hints as to where to invest. While Warren Buffett is popular with value investors, Cathie Wood is perhaps more appealing to investors willing to take on a bit more risk. Her ARK Innovation ETF focuses on a theme of "disruptive innovation" and has generated returns of more than 500% over the past five years -- outperforming the S&P 500 and its 92% gains during that period.
One of her latest moves was to load up on Teladoc Health (NYSE: TDOC), as shares of the telehealth business have been falling in 2021. But with looming competition from Amazon (NASDAQ: AMZN), should investors also buy shares of the company, or is this a move that is only suitable for a fund manager with a broad portfolio to make?
Image source: Getty Images.
Source Fool.com
